Amicus Therapeutics Inc (FOLD)
9.66
+0.16
(+1.68%)
USD |
NASDAQ |
Nov 22, 16:00
9.88
+0.22
(+2.28%)
After-Hours: 20:00
Amicus Therapeutics Debt to Equity Ratio: 2.178 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.178 |
| June 30, 2024 | 2.935 |
| March 31, 2024 | 2.972 |
| December 31, 2023 | 2.422 |
| September 30, 2023 | 2.958 |
| June 30, 2023 | 3.525 |
| March 31, 2023 | 3.828 |
| December 31, 2022 | 3.186 |
| September 30, 2022 | 2.952 |
| June 30, 2022 | 2.253 |
| March 31, 2022 | 1.634 |
| December 31, 2021 | 1.267 |
| September 30, 2021 | 1.032 |
| June 30, 2021 | 1.825 |
| March 31, 2021 | 1.554 |
| December 31, 2020 | 1.359 |
| September 30, 2020 | 1.213 |
| June 30, 2020 | 0.4157 |
| March 31, 2020 | 0.3719 |
| December 31, 2019 | 0.3138 |
| September 30, 2019 | 0.2722 |
| June 30, 2019 | 0.2484 |
| March 31, 2019 | 0.3738 |
| December 31, 2018 | 0.9383 |
| September 30, 2018 | 0.7758 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.3016 |
| March 31, 2018 | 0.3197 |
| December 31, 2017 | 0.4653 |
| September 30, 2017 | 0.3945 |
| June 30, 2017 | 0.5964 |
| March 31, 2017 | 0.5047 |
| December 31, 2016 | 0.4289 |
| September 30, 2016 | 0.1962 |
| June 30, 2016 | 0.1953 |
| March 31, 2016 | 0.1236 |
| December 31, 2015 | 0.1196 |
| September 30, 2015 | 0.132 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.1384 |
| December 31, 2014 | 0.1175 |
| September 30, 2014 | 0.3305 |
| June 30, 2014 | 0.3954 |
| March 31, 2014 | 0.4637 |
| December 31, 2013 | 0.3163 |
| September 30, 2013 | 0.015 |
| June 30, 2013 | 0.0126 |
| March 31, 2013 | 0.0112 |
| December 31, 2012 | 0.0101 |
| September 30, 2012 | 0.0117 |
| June 30, 2012 | 0.018 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3138
Minimum
Dec 2019
3.828
Maximum
Mar 2023
2.010
Average
2.002
Median
Debt to Equity Ratio Benchmarks
| Tonix Pharmaceuticals Holding Corp | 0.1077 |
| Alnylam Pharmaceuticals Inc | 31.64 |
| Insmed Inc | 1.975 |
| Ionis Pharmaceuticals Inc | 1.930 |
| Arbutus Biopharma Corp | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 786.56M |
| Total Liabilities (Quarterly) | 607.73M |
| Shareholders Equity (Quarterly) | 178.82M |
| Current Ratio | 3.152 |
| Net Debt Paydown Yield | 0.02% |